The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-β

Human Reproduction

Volumn 21, Issue 6, 2006, Pages 1380-1386

  Luo, Xiaoping ^a   Levens, Eric ^a   Williams, R Stan ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Abi 2; Gene expression; GnRH analogue; Leiomyoma; TGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ABELSON KINASE INTERACTOR 2; BINDING PROTEIN; GONADORELIN DERIVATIVE; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTERY WALL; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MENSTRUAL CYCLE; MYOMETRIUM; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; TUMOR REGRESSION; UTERUS MYOMA; WESTERN BLOTTING;

EID: 33748996784     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del011     Document Type: Article

References (43)

1. Biesova Z, Piccoli C and Wong WT (1997) Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene 14,233-241.
2. Cheng CK and Leung PC (2005) Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26,283-306.
3. Chegini N (2005) Gene expression and hormonal response. In Brosens I (ed.) Uterine Leiomyomata: Pathogenesis and Management. Taylor & Francis, London.
4. Chegini N, Ma C, Tang XM and Williams RS (2002) Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 8,1071-1078.
5. Chegini N, Luo X, Ding L and Ripley D (2003a) The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 209,9-16.
6. Chegini N, Verala J, Luo X, Xu J and Williams RS (2003b) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 10,161-171.
7. Courtney KD, Grove M, Vandongen H, Vandongen A, LaMantia AS and Pendergast AM (2000) Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol Cell Neurosci 16,244-257.
8. Cowan CA and Henkemeyer M (2001) The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 413,174-179.
9. Dai Z and Pendergast AM (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev 9,2569-2582.
10. Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW et al. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev 12,1415-1424.
11. Dai Z, Kerzic P, Schroeder WG and McNiece IK (2001) Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J Biol Chem 276,28954-28960.
12. Ding L, Xu J, Luo X and Chegini N (2004) Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 89,5549-5557.
13. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS and Chegini N (1996) Suppression of TGF-βs and TGF-β receptors mRNA and protein expression in leiomyomata in women receiving gonadotropin releasing hormone agonist therapy. J Clin Endocrinol Metab 81,3222-3230.
14. Echarri A, Lai MJ, Robinson MR and Pendergast AM (2004) Abl interactor 1 (Abi-1) wave-binding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave-1 levels. Mol Cell Biol 24,4979-4993.
15. Eden S, Rohatgi R, Podtelejnikov AV, Mann M and Kirschner MW (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418,790-793.
16. Fan PD and Goff SP (2000) Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases. Mol Cell Biol 20,7591-7601.
17. Fan PD, Cong F and Goff SP (2003) Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1. Cancer Res 63,873-877.
18. Garcia-Cuellar MP, Schreiner SA, Birke M, Hamacher M, Fey GH and Slany RK (2000) ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+. Oncogene 19,1744-1751.
19. Hernandez SE, Krishnaswami M, Miller AL and Koleske AJ (2004) How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 14,36-44.
20. Ikeguchi A, Yang HY, Gao G and Goff SP (2001) Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1. Oncogene 20,4926-4934.
21. Kunda P, Craig G, Dominguez V and Baum B (2003) Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr Biol 13,1867-1875.
22. Lee BS and Nowak RA (2001) Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF β) and altered responses to the antiproliferative effects of TGF-β. J Clin Endocrinol Metab 86,913-920.
23. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M and Siminovitch K (2005) Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad Sci U S A 102,1098-1103.
24. Levens E, Luo X, Williams RS and Chegini N (2005) Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin releasing hormone analogue (GnRHa) therapy and TGF-β through Smad and MAPK-mediated signalling. Mol Hum Reprod, 11,489-494.
25. Lin TY, Huang CH, Chou WG and Juang JL (2004) Abi enhances Abl-mediated CDC2 phosphorylation and inactivation. J Biomed Sci 11,902-910.
26. Luo X, Ding L, Xu J and Chegini N (2005a) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-{beta}. Endocrinology 146,1097-1118.
27. Luo X, Ding L, Xu J, Williams RS and Chegini N (2005b) Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology 146,1074-1096.
28. Pendergast AM (2002) The AM family kinases: Mechanisms of regulation and signalling. Adv Cancer Res 85,51-100.
29. Rossi MJ, Chegini N and Masterson BJ (1992) Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: Their action in smooth muscle cells in vitro. Endocrinology 130,1716-1727.
30. Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S et al. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401,290-293.
31. Shi Y and Massague J (2003) Mechanisms of TGF-β signalling from cell membrane to the nucleus. Cell 113,685-700.
32. Shi Y, Alin K and Goff SP (1995) Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes Dev 9,2583-2597.
33. Soderling SH, Binns KL, Wayman GA, Davee SM, Ong SH, Pawson T and Scott JD (2002) The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nat Cell Biol 4,970-975.
34. Stradal T, Courtney KD, Rottner K, Hahne P, Small JV and Pendergast AM (2001) The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr Biol 11,891-895.
35. Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M and Hayashi Y (1998) ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23). Blood 92,1125-1130.
36. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H and Shishido T (2003) Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 278,21685-21692.
37. Tsibris JC, Segars J, Coppola D, Mane S, Wilbanks GD, O'Brien WF and Spellacy WN (2002) Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78,114-121.
38. Van Etten RA (2003) c-Abl regulation: A tail of two lipids. Curr Biol 13,R608-R610.
39. Wang B, Mysliwiec T, Krainc D, Jensen RA, Sonoda G, Testa JR, Golemis EA and Kruh GD (1996) Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. Oncogene 12,1921-1929.
40. Wang H, Mahadevappa M, Yamamoto K, Wen Y, Chen B, Warrington JA and Polan ML (2003) Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 80,266-276.
41. Xu J, Luo X and Chegini N (2003) Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 88,1350-1361.
42. Yamamoto A, Suzuki T and Sakaki Y (2001) Isolation of hNap1BP which interacts with human Nap1 (NCKAP1) whose expression is down-regulated in Alzheimer's disease. Gene 271,159-169.
43. Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim KS, Jenkins EC, Trenkner E and Kotula L (1998) Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J Biol Chem 273,13681-13692.